Adrenocortical Hyperfunction: Clinical Trials

9 trials for Adrenocortical Hyperfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 recruiting. 9 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Recruiting 9
Phase 12Recruiting 2

Follow Adrenocortical Hyperfunction: new trials by email Literature Review of Adrenocortical Hyperfunction trials Research Report on Adrenocortical Hyperfunction

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
Metyrapone 250 mg Oral Tablets, Placebo - Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS)
Phase 2RecruitingMayo Clinic902026-10-012026-09-25
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Osilodrostat 1 MG - Mild Autonomous Cortisol Secretion, Autonomous Cortisol Secretion (ACS)
Phase 2RecruitingMayo Clinic152026-01-142026-02-11
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
clofutriben, Placebo - Type 2 Diabetes, Cortisol Excess
Phase 2RecruitingSparrow Pharmaceuticals15002025-11-292026-10-06
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Desmopressin, Dexamethasone - Cushing Syndrome
Phase 2RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1402024-12-122026-08-31
Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
[18F]CETO tracer, Dexamethasone oral, Adrenal vein sampling - Primary Aldosteronism
Phase 1 / Phase 2RecruitingUniversity Medical Center Groningen122024-11-062025-01-27
Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
[68Ga]Ga-PentixaFor - Hyperaldosteronism, Hypercortisolism
Phase 2RecruitingNational Cancer Institute (NCI)802024-09-232026-10-22
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
Al18F-NOTA-Pentixafor PET/CT - Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma
Phase 1 / Phase 2RecruitingPeking Union Medical College Hospital1502023-12-302025-02-26
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
LCI699 - Cushing Syndrome
Phase 2RecruitingRECORDATI GROUP122021-04-282026-03-27
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
DOTATATE PET-CT, F-DOPA PET CT, CT scan - ACTH, Cushing's Syndrome
Phase 2RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)802014-02-122026-10-02

Narrower conditions

Cushing Syndrome (7)  ·  ACTH Syndrome, Ectopic (3)  ·  Hyperaldosteronism (3)  ·  Adrenal Hyperplasia, Congenital (2)  ·  Adenoma (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Disease (1)  ·  Pituitary Diseases (1)

Broader conditions

Adrenal Gland Diseases (9)  ·  Endocrine System Diseases (9)  ·  Neoplasms (4)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Paraneoplastic Endocrine Syndromes (3)  ·  Paraneoplastic Syndromes (3)  ·  Adrenogenital Syndrome (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Disorders of Sex Development (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genetic Diseases, Inborn (2)

Interventions

Dexamethasone (2)  ·  Osilodrostat (2)  ·  ASP3662 (1)  ·  Deamino Arginine Vasopressin (1)  ·  Metyrapone (1)  ·  fluorodopa F 18 (1)  ·  gallium Ga 68 dotatate (1)

Sponsors

Mayo Clinic (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  National Cancer Institute (NCI) (1)  ·  Peking Union Medical College Hospital (1)  ·  RECORDATI GROUP (1)  ·  Sparrow Pharmaceuticals (1)  ·  University Medical Center Groningen (1)

Countries

United States (7)  ·  Belgium (1)  ·  Bulgaria (1)  ·  China (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Slovenia (1)  ·  United Kingdom (1)

Top investigators

Lynnette K Nieman, M.D. (2)  ·  Dr. M.N. Kerstens (1)  ·  Irina Bancos, MD (1)  ·  Irina Bancos, MD, MS (1)  ·  Maria Liza Lindenberg, M.D. (1)  ·  Recordati AG (1)

Results publications

PMID 33859526, PMID 36074157, PMID 42535456

NIH funding

2018 (1), 2023 (1)